OAN Newsroom
UPDATED 5:51 PM PT – Thursday, December 8, 2022
The Food and Drug Administration (FDA) has changed their emergency use authorization (EUAs) for COVID vaccines to now include children from five years old to six-months-old.
The agency’s top vaccine regulator, Peter Marks, announced the emergency use authorization of an updated bivalent COVID-19 vaccine early on Thursday.
This comes after Pfizer and BioNTech sought an authorization from the agency on Monday for the vaccines use in children under the age of five.
Currently, the FDA recommends children to receive doses of the COVID-19 vaccine. Officials are reportedly expecting to receive the data needed to support a fourth dose in January.
CDC data shows that only 6.4% percent of children under the age of two have received at least one dose of a COVID-19 vaccine.